Press release
Antibody Drug Conjugates Market Size 2024 : Opportunity Analysis and Industry Forecast 2030
Antibody Drug Conjugates Market
Some of the key players involved in the Market are:
• F. Hoffmann-La Roche Ltd. - Holding a 36.24% market share, Roche leads with products like Kadcyla (ado-trastuzumab emtansine) and Polivy (polatuzumab vedotin), both of which have shown significant revenue growth .
• Daiichi Sankyo Company, Limited - With a 25.59% market share, Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) has seen its revenue double in 2022 compared to 2021, reflecting its strong market position .
• Seagen Inc. - Acquired by Pfizer, Seagen holds a 17.97% market share and is known for its flagship product Adcetris (brentuximab vedotin), used in treating various lymphomas.
• Gilead Sciences Inc. - Holding an 8.86% market share, Gilead expanded its oncology portfolio by acquiring Immunomedics, the maker of Trodelvy (sacituzumab govitecan) .
• Genmab - With a 3% market share, Genmab collaborates on ADC development, including partnerships with companies like Seagen .
• Pfizer Inc. - Post-acquisition of Seagen, Pfizer holds a 2.85% market share and aims to generate $10 billion annually from ADCs by 2030 .
• GlaxoSmithKline plc (GSK) - With a 1.62% market share, GSK is investing in ADCs, including discussions to acquire biotech firms specializing in cancer drugs .
• ADC Therapeutics SA - Holding a 1.37% market share, this Swiss company focuses exclusively on ADC development .
• AstraZeneca plc - With a 1.03% market share, AstraZeneca is investing in ADC manufacturing facilities and aims to launch 20 new medicines by 2030 .
• RemeGen - A Chinese biopharmaceutical company holding a 0.74% market share, contributing to the global ADC landscape .
Get Full PDF Sample Copy of Report (Including Full TOC, List of Tables & Figures, Chart) Click Here: https://www.alliedmarketresearch.com/request-sample/1467
What are the Driving Factors Of Antibody Drug Conjugates (ADCs) Market?
The growth of global AI in healthcare market is mainly driven by rise in the volume of healthcare data and increase in complications of datasets. This leads to increase in the need for AI in healthcare in the market. The impact of the COVID-19 has positively impacted the growth of various healthcare-related sectors, one of which is AI in healthcare.
Antibody Drug Conjugates (ADCs) Market Segmentation can be done based on several factors, including:
The Antibody Drug Conjugates (ADCs) market can be segmented based on various factors. Here are some common segmentation approaches:
By Type of Cancer: ADCs are designed to target specific types of cancer cells. The market can be segmented based on the type of cancer that ADCs are developed to treat, such as breast cancer, lung cancer, lymphoma, leukemia, ovarian cancer, and others.
By Component: ADCs consist of three main components: the monoclonal antibody, the cytotoxic payload, and the linker that connects them. The market can be segmented based on these components, focusing on the different types of antibodies, payloads, and linkers used in ADC development.
By Target Antigen: ADCs are designed to bind to specific antigens present on cancer cells. The market can be segmented based on the target antigen, such as HER2 (human epidermal growth factor receptor 2), CD30, CD33, CD22, and others.
By Stage of Development: ADCs can be in different stages of development, ranging from early-stage research and preclinical studies to clinical trials and approved products. The market can be segmented based on the stage of development to differentiate between ADCs in the pipeline and those already commercialized.
By Region: The ADC market can also be segmented geographically, considering regional markets such as North America, Europe, Asia-Pacific, and the rest of the world. This segmentation helps understand the regional demand, regulatory landscape, and market dynamics for ADCs.
By End User: The market can be segmented based on the end users of ADCs, including hospitals, specialty clinics, research institutes, and pharmaceutical companies.
Purchase the Report: https://www.alliedmarketresearch.com/purchase-enquiry/1467
Our Market Research Solution Provides You Answer to Below Mentioned Question:
Which are the driving factors responsible for the growth of market?
Which are the roadblock factors of this market?
What are the new opportunities, by which market will grow in coming years?
What are the trends of this market?
Which are main factors responsible for new product launch?
How big is the global & regional market in terms of revenue, sales and production?
How far will the market grow in forecast period in terms of revenue, sales and production?
Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
Which region has more opportunities?
Region Analysis
North America
(U.S., Canada, Mexico)
Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antibody Drug Conjugates Market Size 2024 : Opportunity Analysis and Industry Forecast 2030 here
News-ID: 4008989 • Views: …
More Releases from Allied Market Research (AMR)
Online Music Streaming Market Demand will reach a value of US$ 24,711.3 million …
The global online music streaming market size is expected to reach $24,711.3 million by 2027 at a CAGR of 12.34% from 2021 to 2027.
Request The Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/11521
Online music streaming is a means of delivering music without downloading any file from the internet. Music is stored on the servers' database and is instantly transferred to the streamer or users' device in real…
Low-E Glass Market Growth Trends: Global Analysis of Leading Players and Busines …
According to the study, the global low-e glass market was valued at $11.9 billion in 2022 and is projected to reach $21.0 billion by 2032, growing at a CAGR of 5.9% from 2023 to 2032.
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A15849
Market Drivers and Challenges:
- The growing emphasis on energy efficiency and cost reduction is propelling the demand for low-emissivity (Low-E) glass globally. Despite higher upfront costs compared to traditional glass,…
Sunflower Lecithin Market: Industry Development Challenges, Opportunities & Key …
According to the report, the global sunflower lecithin market was valued at $324.6 million in 2018 and is projected to reach $754.8 million by 2032, growing at a CAGR of 5.7% from 2023 to 2032.
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A156654
What is Sunflower Lecithin?
Sunflower lecithin is a natural lipid blend derived from sunflower seeds, either mechanically or chemically, and is prized for its superior emulsifying and stabilizing properties. Composed primarily…
Bio-Renewable Chemicals Companies Analysis and Developments by 2031
According to the report, the global bio-renewable chemicals market was valued at $2.5 billion in 2021 and is projected to reach $7.4 billion by 2031, registering a CAGR of 11.6% from 2022 to 2031. The study provides an in-depth analysis of market dynamics, emerging trends, key investment areas, value chains, regional insights, and competitive landscapes.
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/156
Market Drivers, Restraints, and Opportunities
Drivers:
- Technological advancements and innovations in…
More Releases for ADC
ADC Market: Transforming Cancer Treatment
The global market for antibody-drug conjugates (ADCs) was valued at US$ 11.32 billion in 2023 and is expected to reach US$ 27.37 billion by 2033, growing at a compound annual growth rate (CAGR) of 9.23% from 2024 to 2033. This growth is primarily driven by the increasing prevalence of cancer and the growing demand for safe and effective treatments.
Antibody Drug Conjugates: A Growing Force in Cancer Treatment and Market Expansion
Key…
With Knockout ADC Innovations, Creative Biolabs Took Center Stage at the 2024 Wo …
Creative Biolabs wrapped up a successful show at the 15th Annual World ADC San Diego in the beginning of November, where its third year of participation, highlighting its dedication to the advancement of antibody-drug conjugate (ADC) technology.
New York, USA - November 13, 2024 - Creative Biolabs seized the spotlight at Booth 313 by offering groundbreaking solutions across the entire ADC development spectrum, which demonstrate their unrivaled expertise and dedication to…
Showing Off Their ADC Game: Creative Biolabs Hits the 15th Annual World ADC Summ …
From November 4, Creative Biolabs will be back at the 15th Annual World ADC Summit in San Diego, marking its fourth year at the leading global gathering featuring innovative conjugates.
New York, USA - November 6, 2024 - Creative Biolabs invites all ADC enthusiasts, from new entrants to seasoned experts, to explore its comprehensive suite of ADC solutions and experience the latest in antibody-drug conjugate (ADC) innovation at Booth #313.
Image: https://www.getnews.info/uploads/0c59d26f78bf6dd58aafee5bc68d7d8c.jpg
"2023…
ADC Drugs For Breast Cancer Treatment
Breast cancer is the malignant tumor with the highest morbidity and mortality among women worldwide. At present, the main therapeutic methods include surgery, chemotherapy, radiotherapy, endocrine therapy and targeted therapy, etc. The development and marketing of new drugs have far-reaching significance in improving the survival of breast cancer patients and changing the pattern of breast cancer treatment.
On February 24, 2023, The NMPA approved Enhertu, an injectable drug developed jointly by…
Analog-to-Digital Converters Market by Product (Ramp ADC, Integrating ADC, Succe …
Analog-to-Digital Converters Market by Product (Ramp ADC, Integrating ADC, Successive Approximation ADC, Delta-sigma ADC, and Others (Pipelined/Flash ADC)), and Application (Consumer Electronics and Industrial) - Global Opportunity Analysis and Industry Forecast, 2017-2023
Full Report : https://www.alliedmarketresearch.com/analog-to-digital-converters-market
Increasing disposable income and technological advancements supplement the analog-to-digital converters market. However, complex design of the ADC hampers this market growth. On the other hand, encouragement in digitization of work processes by government in emerging economies,…
Global Data Converters Market Report 2017 (Analog to Digital Converter, Current …
The research report titled Global Data Converters Sales Market Report 2017 market size and forecast and overview on current market trends.
This report studies sales (consumption) of Global Data Converters Market 2017, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
National Semiconductor
Nippon Precision Circuits Inc
Micro Analog systems
Microchip Technology.
TelCom Semiconductor, Inc
Vishay Siliconix
Texas…
